Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| biote Corp (Class A) | Marc D. Beer | Director | Other type of transaction at price $ 0.00 per share. | 06 Jan 2023 | 865,384 | 2,967,092 | - | 0 | Class V Common Stock | |
| biote Corp (Class A) | Marc D. Beer | Director | 06 Jan 2023 | 865,384 | 2,967,092 | - | - | Retained Biote Units | ||
| biote Corp (Class A) | Marc D. Beer | Director | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 06 Jan 2023 | 865,384 | 0 | - | 3 | 2,596,152 | Class A Common Stock |
| biote Corp (Class A) | Marc D. Beer | Director | 06 Jan 2023 | 865,384 | 865,384 | - | 0 | Class A Common Stock | ||
| biote Corp (Class A) | Teresa S. Weber | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 06 Jan 2023 | 865,384 | 2,967,092 | - | 0 | Class V Common Stock | |
| biote Corp (Class A) | Teresa S. Weber | Director, Chief Executive Officer | 06 Jan 2023 | 865,384 | 2,967,092 | - | - | Retained Biote Units | ||
| biote Corp (Class A) | Teresa S. Weber | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 06 Jan 2023 | 865,384 | 85,040 | - | 3 | 2,596,152 | Class A Common Stock |
| biote Corp (Class A) | Teresa S. Weber | Director, Chief Executive Officer | 06 Jan 2023 | 865,384 | 950,424 | - | 0 | Class A Common Stock | ||
| Great Elm Grp Inc | Jason W. Reese | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 06 Jan 2023 | 460,900 | 5,620,000 (22%) | 1% | 2.2 | 1,000,153 | Common Stock |
| Great Elm Grp Inc | Jason W. Reese | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 06 Jan 2023 | 460,900 | 5,159,100 (20%) | 1% | 2.2 | 1,000,153 | Common stock, par value $0.01 per share ("Common Stock") |
| EyePoint Pharma Inc | Nancy S. Lurker | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 450,800 | 450,800 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 420,780 | 420,780 | - | - | Stock Option (Right to Buy) | |
| Relmada Therapeutics Inc | Cedric O'Gorman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Thomas Andrew Butler | Director, Chief Executive Officer, Ten Percent Owner | 06 Jan 2023 | 354,350 | 354,350 | - | - | Stock Option (Right to Buy) | ||
| Precipio Inc | Ilan Danieli | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Daniel R. Faga | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 194,900 | 194,900 | - | - | Stock Option (right to buy) | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 188,585 | 188,585 | - | - | Employee Stock Option | |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 06 Jan 2023 | 180,000 | 180,000 | - | - | Class A Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 06 Jan 2023 | 180,000 | 24,896,278 | - | - | Class B Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 06 Jan 2023 | 180,000 | 0 | - | 2.2 | 396,342 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 06 Jan 2023 | 152,159 | 17,138,881 | - | 1.5 | 230,825 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 06 Jan 2023 | 152,159 | 17,301,244 | - | 1.5 | 230,825 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 06 Jan 2023 | 152,159 | 17,301,250 | - | 1.5 | 230,825 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 06 Jan 2023 | 152,094 | 17,291,040 | - | 1.5 | 226,772 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 06 Jan 2023 | 152,094 | 17,453,403 | - | 1.5 | 226,772 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 06 Jan 2023 | 152,094 | 17,453,409 | - | 1.5 | 226,772 | Class A Common Stock |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 06 Jan 2023 | 150,000 | 24,746,278 | - | - | Class B Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 06 Jan 2023 | 150,000 | 0 | - | 2.4 | 353,085 | Class A Common Stock |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 06 Jan 2023 | 150,000 | 150,000 | - | - | Class A Common Stock | ||
| Stitch Fix Inc (Class A) | Katrina Lake | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 150,000 | 150,000 | - | - | Class A Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 131,599 | 564,700 (4%) | 0% | 0 | Common Stock | |
| Biomea Fusion Inc | Franco Valle | Chief Financial Officer | 06 Jan 2023 | 126,300 | 126,300 | - | - | Stock Option (Right to Buy) | ||
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Sale of securities on an exchange or to another person at price $ 36.03 per share. | 06 Jan 2023 | 125,000 | 3,303,186 (0%) | 0% | 36.0 | 4,503,750 | Common Stock |
| EyePoint Pharma Inc | Jay S. Duker | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 124,755 | 124,755 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Rainer M. Erdtmann | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 118,000 | 118,000 | - | - | Stock Option (Right to Buy) | |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 89.28 per share. | 06 Jan 2023 | 108,835 | 7,659,373 (18%) | 0% | 89.3 | 9,716,789 | Common Stock |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 106,189 | 396,432 | - | 0 | Common Stock | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 91,655 | 91,655 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Dario A. Paggiarino | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 91,655 | 91,655 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | David Scott Jones | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 91,655 | 91,655 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Michael C. Pine | Chief Corp Dev.&Strat. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 91,655 | 91,655 | - | - | Stock Option (Right to Buy) | |
| Mission Produce Inc | Stephen J. Barnard | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 86,831 | 157,037 | - | 0 | COMMON STOCK | |
| Warner Bros. (Class A) | David M. Zaslav | Director, Chief Executive Officer & Pres | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.32 per share. | 06 Jan 2023 | 78,428 | 4,015,102 (2%) | 0% | 11.3 | 887,805 | Series A Common Stock |
| Precipio Inc | Matthew Gage | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Daniel R. Faga | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 71,400 | 71,400 | - | - | Restricted Stock Unit | |
| SI-BONE Inc | Laura A. Francis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 70,252 | 396,399 (1%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Laura A. Francis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 70,252 | 466,651 (1%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 67,070 | 67,070 | - | - | Stock Option (right to buy) | |
| Outset Medical Inc | Steven Williamson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 64,724 | 126,547 | - | 0 | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 60,530 | 60,530 | - | - | Stock Option (right to buy) | |
| SI-BONE Inc | Anthony J. Recupero | President, Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 57,478 | 220,690 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Anshul Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 57,478 | 146,965 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 57,260 | 57,260 | - | - | Stock Option (right to buy) | |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 89.68 per share. | 06 Jan 2023 | 56,907 | 7,556,148 (17%) | 0% | 89.7 | 5,103,420 | Common Stock |
| Outset Medical Inc | Martin Vazquez | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 56,634 | 105,924 | - | 0 | Common Stock | |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | 06 Jan 2023 | 56,634 | 98,662 | - | 0 | Common Stock | ||
| SI-BONE Inc | Michael A Pisetsky | SVP, Ops & Adm/Chief Legal Ofr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 56,445 | 172,507 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Matthew W. Tonn | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 55,908 | 55,908 | - | - | Employee Stock Option | |
| FreightCar America Inc | Jesus Gil | Director, VP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 50,067 | 50,067 | - | - | Employee Stock Option | |
| FreightCar America Inc | Michael Anthony Riordan | VP Finance, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 50,067 | 50,067 | - | - | Employee Stock Option | |
| Conagra Brands | Robert G. Wise | SVP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 40.90 per share. | 06 Jan 2023 | 50,000 | 22,717 (0%) | 0% | 40.9 | 2,045,000 | Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Eos Energy Enterprises Inc (Class A) | John J. Tedone | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| First Internet Bancorp | David B. Becker | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 50,000 | 381,645 (3%) | 0% | 0 | Common Stock | |
| Stitch Fix Inc (Class A) | Katrina Lake | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 50,000 | 50,000 | - | - | Class A Common Stock | |
| Hewlett Packard | Jeremy K. Cox | SVP Controller and CTO | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 06 Jan 2023 | 47,307 | 0 (0%) | 0% | 17.0 | 804,905 | Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. | 06 Jan 2023 | 47,101 | 94,415 (0%) | 0% | 5.6 | 265,650 | Common Stock |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.61 per share. | 06 Jan 2023 | 46,318 | 7,613,055 (18%) | 0% | 90.6 | 4,196,874 | Common Stock |
| Helios Tech Inc | Josef Matosevic | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 39,737 | 39,737 | - | - | Restricted Stock Units | |
| Helios Tech Inc | Josef Matosevic | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 39,737 | 39,737 | - | - | Performance-Based Restricted Stock Units | |
| FreightCar America Inc | Matthew W. Tonn | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 39,014 | 209,569 (1%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | John L. Brottem | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 38,834 | 69,878 | - | 0 | Common Stock | |
| Outset Medical Inc | Jean-Olivier Racine | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 38,834 | 79,170 | - | 0 | Common Stock | |
| Knowles Corp | Daniel J. Giesecke | Senior Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.73 per share. | 06 Jan 2023 | 38,240 | 98,240 (0%) | 0% | 17.7 | 677,995 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 36,570 | 198,724 | - | - | Stock Option (Right to Buy) | |
| CSP Inc | Victor Dellovo | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 35,000 | 361,605 (8%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Jesus Gil | Director, VP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 34,938 | 93,159 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Michael Anthony Riordan | VP Finance, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 34,938 | 105,745 (0%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | Stacey L. Porter | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 34,466 | 64,891 | - | 0 | Common Stock | |
| Terreno Realty Corp | Michael A. Coke | Director, PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 33,456 | 160,447 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Terreno Realty Corp | W. Blake Baird | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 33,456 | 160,447 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Genasys Inc | Dennis D. Klahn | CFO/Secretary | 06 Jan 2023 | 30,000 | 57,696 (0%) | 0% | - | Common Stock | ||
| Precipio Inc | Kathleen D. Laporte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Richard A. Sandberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Douglas Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Jeffrey Cossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | David S. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Resources Connection Inc | Anthony Cherbak | Director | 06 Jan 2023 | 30,000 | 15,000 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Resources Connection Inc | Anthony Cherbak | Director | 06 Jan 2023 | 30,000 | 75,788 (0%) | 0% | 11.1 | 331,500 | Common Stock | |
| Resources Connection Inc | Anthony Cherbak | Director | 06 Jan 2023 | 30,000 | 45,788 (0%) | 0% | 16.4 | 490,743 | Common Stock | |
| Mission Produce Inc | Bryan E. Giles | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 29,522 | 101,852 | - | 0 | COMMON STOCK | |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 25,606 | 25,606 | - | - | Restricted Stock Units | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 24,580 | 24,580 | - | - | Restricted Stock Unit | |
| Quanterix Corp | Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 24,153 | 24,153 | - | - | Stock Option (right to buy) | |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 23,893 | 420,325 | - | 0 | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 22,180 | 22,180 | - | - | Restricted Stock Unit | |
| Mission Produce Inc | Juan R. Wiesner | Dir, S. America Ops | 06 Jan 2023 | 21,707 | 1,230,064 | - | 0 | COMMON STOCK | ||
| Mission Produce Inc | Joanne C. Wu | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 21,707 | 40,824 | - | 0 | COMMON STOCK | |
| Mission Produce Inc | Timothy Bulow | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 21,707 | 21,707 | - | 0 | COMMON STOCK | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 20,980 | 20,980 | - | - | Restricted Stock Unit | |
| Target Hospitality Corp (Class A) | Jason Paul Vlacich | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.83 per share. | 06 Jan 2023 | 20,000 | 39,355 (0%) | 0% | 10.8 | 216,600 | Common Stock, par value $0.0001 per share |
| Target Hospitality Corp (Class A) | Jason Paul Vlacich | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 06 Jan 2023 | 20,000 | 19,355 (0%) | 0% | 16.3 | 326,600 | Common Stock, par value $0.0001 per share |
| Target Hospitality Corp (Class A) | Jason Paul Vlacich | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 20,000 | 9,941 | - | - | Employee Stock Option (right to buy) | |
| PIMCO Dynamic Income Opportunities Fund | Gregory Weston Hall | SEE REMARKS | Purchase of securities on an exchange or from another person at price $ 13.49 per share. | 06 Jan 2023 | 20,000 | 70,000 | - | 13.5 | 269,754 | COMMON SHARES |
| SI-BONE Inc | Anthony J. Recupero | President, Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 19,159 | 239,849 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Anshul Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 19,159 | 166,124 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Celia Perez | GC and Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 19,022 | 19,022 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | Joseph E. Creed | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 151.12 per share. | 06 Jan 2023 | 18,294 | 18,294 (0%) | 0% | 151.1 | 2,764,589 | Common Stock |
| Caterpillar | Joseph E. Creed | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 18,294 | 0 | - | - | Employee Stock Options | |
| Caterpillar | Joseph E. Creed | Group President | Sale of securities on an exchange or to another person at price $ 249.00 per share. | 06 Jan 2023 | 18,294 | 0 (0%) | 0% | 249 | 4,555,206 | Common Stock |
| Seacoast Banking Corp Of Florida | Dennis S. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.63 per share. | 06 Jan 2023 | 17,975 | 180,260 (0%) | 0% | 12.6 | 227,024 | Common Stock |
| Seacoast Banking Corp Of Florida | Dennis S. Hudson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 17,975 | 0 | - | - | Common Stock Right to Buy | |
| Aramark | Abigail Charpentier | SVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 17,768 | 17,768 | - | - | Stock Option (Right to Buy) | |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 16,283 | 58,611 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 16,283 | 53,184 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 16,102 | 16,102 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | Juan Carlos Fuentes Sierra | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 15,217 | 25,217 (0%) | 0% | 0 | Common Stock | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 06 Jan 2023 | 15,000 | 93,812 | - | 19.0 | 285,584 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 15,000 | 252,380 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 06 Jan 2023 | 15,000 | 108,812 | - | 2.1 | 31,200 | Common Stock |
| FiscalNote Holdings Inc (Class A) | Gerald Yao | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 14,785 | 1,113,993 | - | - | Class B Common Stock | |
| FiscalNote Holdings Inc (Class A) | Gerald Yao | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 14,785 | 68,305 | - | - | Class B Common Stock | |
| SkyWater Tech Inc | Thomas R. Lujan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 14,000 | 461,198 | - | 0 | Common Stock | |
| Terreno Realty Corp | Jaime J. Cannon | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 13,941 | 67,314 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Terreno Realty Corp | John T. Meyer | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 13,941 | 67,314 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Natural Resource Partners LP - Unit | Christopher J. Zolas | CFO and Treasurer | Other type of transaction at price $ 0.00 per share. | 06 Jan 2023 | 13,355 | 8,904 (0%) | 0% | 0 | Common Units | |
| Transocean Ltd | David A. Tonnel | SVP - CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 06 Jan 2023 | 13,069 | 325,875 (0%) | 0% | 5.0 | 64,692 | Registered Shares |
| Nuwellis Inc | Lynn L. Blake | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 12,417 | 12,417 | - | - | Nonstatutory Stock Option (right to buy) | |
| Privia Health Group Inc | William M. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 21.24 per share. | 06 Jan 2023 | 12,115 | 5,832,968 | - | 21.2 | 257,323 | Common Stock, $0.01 par value per share |
| FreightCar America Inc | Celia Perez | GC and Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 11,682 | 11,682 | - | - | Employee Stock Option | |
| Seacoast Banking Corp Of Florida | Dennis S. Hudson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.90 per share. | 06 Jan 2023 | 11,644 | 168,616 (0%) | 0% | 31.9 | 371,444 | Common Stock |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Hollings C. Renton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | James N. Topper | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| Halliburton | Eric J. Carre | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Jan 2023 | 10,518 | 129,984 (0%) | 0% | 40 | 420,720 | Common Stock |
| Lucky Strike Entertainment Corp (Class A) | Thomas F. Shannon | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 06 Jan 2023 | 10,203 | 2,389,797 | - | 13.7 | 140,291 | Class A Common Stock |
| SkyWater Tech Inc | Thomas R. Lujan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,060 | 471,258 | - | 0 | Common Stock | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 06 Jan 2023 | 10,000 | 291,498 (0%) | 0% | 38 | 380,000 | Common Stock $.01 Par Value ND |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 06 Jan 2023 | 10,000 | 301,498 (0%) | 0% | 36 | 360,000 | Common Stock $.01 Par Value ND |
| Hudson Tech Inc | Stephen P. Mandracchia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 10,000 | 396,756 (0%) | 0% | 0 | Common Stock | |
| Marvell Tech Inc | Willem A. Meintjes | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 34.92 per share. | 06 Jan 2023 | 10,000 | 72,896 (0%) | 0% | 34.9 | 349,200 | Common Stock |
| First Internet Bancorp | David B. Becker | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 9,885 | 391,530 (4%) | 0% | 0 | Common Stock | |
| Acadia Pharma Inc | Stephen R. Davis | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 9,528 | 9,528 | - | - | Restricted Stock Units | |
| Acadia Pharma Inc | Stephen R. Davis | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 9,528 | 88,537 (0%) | 0% | - | Common Stock | |
| FreightCar America Inc | Juan Carlos Fuentes Sierra | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 9,346 | 9,346 | - | - | Employee Stock Option | |
| TG Therapeutics Inc | Yann Echelard | Director | Purchase of securities on an exchange or from another person at price $ 10.64 per share. | 06 Jan 2023 | 9,000 | 201,848 (0%) | 0% | 10.6 | 95,760 | Common Stock |
| CSP Inc | Gary W. Levine | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 8,500 | 90,180 (2%) | 0% | 0 | Common Stock | |
| CSP Inc | Michael Newbanks | VP Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 8,500 | 41,807 (0%) | 0% | 0 | Common Stock | |
| Helios Tech Inc | Tricia L. Fulton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 7,935 | 7,935 | - | - | Performance-Based Restricted Stock Units | |
| Helios Tech Inc | Tricia L. Fulton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 7,934 | 7,934 | - | - | Restricted Stock Units | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Jan 2023 | 7,871 | 10,284 | - | 2.1 | 16,844 | Common Stock |
| Lulus Fashion Lounge Holdings Inc | Eric Liaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 7,616 | 39,347 | - | 0 | Common Stock | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.62 per share. | 06 Jan 2023 | 7,492 | 2,792 | - | 25.6 | 191,949 | Common Stock |
| Glimpse Grp Inc | Lyron L. Bentovim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.85 per share. | 06 Jan 2023 | 7,099 | 37,224 | - | 2.8 | 20,232 | Common Stock |
| CSP Inc | Gary Southwell | VP and GM | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 7,000 | 35,051 (0%) | 0% | 0 | Common Stock | |
| Xponential Fitness Inc (Class A) | Megan Moen | EVP, Finance | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 06 Jan 2023 | 6,974 | 24,159 | - | 26.3 | 183,390 | Class A Common Stock |
| Sunrun Inc | Paul S. Dickson | Chief Revenue Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 6,500 | 154,536 (0%) | 0% | 0 | Common Stock | |
| First Internet Bancorp | Nicole S. Lorch | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 6,178 | 49,161 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial | Karl J. Krapek | Director | 06 Jan 2023 | 6,126 | 0 | - | - | Notional Shares - Optional | ||
| Halliburton | Van H. Beckwith | EVP, Secretary and CLO | Sale of securities on an exchange or to another person at price $ 39.42 per share. | 06 Jan 2023 | 5,477 | 250,026 (0%) | 0% | 39.4 | 215,903 | Common Stock |
| Xponential Fitness Inc (Class A) | Megan Moen | EVP, Finance | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 06 Jan 2023 | 5,402 | 31,133 | - | 25.4 | 137,336 | Class A Common Stock |
| Toro Co. | Janet K. Cooper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.67 per share. | 06 Jan 2023 | 5,038 | 6,694 (0%) | 0% | 37.7 | 189,781 | Common Stock |
| Toro Co. | Janet K. Cooper | Director | Sale of securities on an exchange or to another person at price $ 114.00 per share. | 06 Jan 2023 | 5,038 | 1,656 (0%) | 0% | 114 | 574,332 | Common Stock |
| Toro Co. | Janet K. Cooper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 5,038 | 0 | - | - | Non-Qualified Stock Option | |
| Glimpse Grp Inc | Maydan Rothblum | Director, CFO and COO | Grant, award, or other acquisition of securities at price $ 2.85 per share. | 06 Jan 2023 | 5,036 | 481,414 | - | 2.9 | 14,353 | Common Stock |
| Aramark | Abigail Charpentier | SVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 5,006 | 28,442 (0%) | 0% | 0 | Common Stock | |
| J.Jill Inc | Michael M Rahamim | Director | Sale of securities on an exchange or to another person at price $ 26.49 per share. | 06 Jan 2023 | 5,000 | 26,258 (0%) | 0% | 26.5 | 132,450 | Common Stock |
| Lamb Weston | Sharon L. Miller | SENIOR VICE PRESIDENT | 06 Jan 2023 | 5,000 | 54,116 (0%) | 0% | 100 | 500,000 | Common Stock | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 06 Jan 2023 | 5,000 | 98,812 | - | 2.1 | 10,400 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 5,000 | 247,380 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.17 per share. | 06 Jan 2023 | 5,000 | 93,812 | - | 19.2 | 95,829 | Common Stock |
| Helios Tech Inc | Tricia L. Fulton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Nike | Monique S. Matheson | EVP: CHRO | 06 Jan 2023 | 5,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Nike | Monique S. Matheson | EVP: CHRO | 06 Jan 2023 | 5,000 | 60,213 (0%) | 0% | 124 | 620,000 | Class B Common Stock | |
| Nike | Monique S. Matheson | EVP: CHRO | 06 Jan 2023 | 5,000 | 65,213 (0%) | 0% | 57.9 | 289,350 | Class B Common Stock | |
| Glimpse Grp Inc | Jeffrey Ralph Meisner | Director, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 2.85 per share. | 06 Jan 2023 | 4,715 | 84,016 | - | 2.9 | 13,438 | Common Stock |
| Priority Technology Holdings | Christina M. Favilla | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 4,612 | 83,366 (0%) | 0% | 0 | Common Stock | |
| Priority Technology Holdings | Christina M. Favilla | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 4,612 | 0 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | 06 Jan 2023 | 4,612 | 0 | - | - | Restricted Stock Unit | ||
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | 06 Jan 2023 | 4,612 | 9,325,792 (13%) | 0% | 0 | Common Stock | ||
| Priority Technology Holdings | Michael K. Passilla | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 4,612 | 83,366 (0%) | 0% | 0 | Common Stock | |
| Priority Technology Holdings | Michael K. Passilla | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 4,612 | 0 | - | - | Restricted Stock Unit | |
| Glimpse Grp Inc | Tyler Gates | Chief Futurist Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,608 | 4,608 | - | - | Stock Options (right to buy) | |
| Glimpse Grp Inc | David J. Smith | Director, Chief Creative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,500 | 4,500 | - | - | Stock Options (right to buy) | |
| Amylyx Pharma Inc | Joshua Cohen | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 06 Jan 2023 | 4,122 | 2,894,463 | - | 36.1 | 148,717 | Common Stock |
| Amylyx Pharma Inc | Justin Klee | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 06 Jan 2023 | 4,122 | 2,894,463 | - | 36.1 | 148,717 | Common Stock |
| Greenbrier Cos. Inc | David L. Starling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 11,523 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Charles J. Swindells | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 40,982 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Graeme Allan Jack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 29,459 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Thomas B. Fargo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 9,918 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | William A. Furman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 257,068 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Wendy L. Teramoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 29,245 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Antonio O. Garza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 17,072 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | James R. Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 15,459 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Kelly M. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 4,050 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Wanda F. Felton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 4,050 | 7,505 (0%) | 0% | 0 | Common Stock | |
| Brunswick Corp | Brett A. Dibkey | EVP & President Navico Group | 06 Jan 2023 | 4,032 | 17,236 (0%) | 0% | 76.8 | 309,698 | Common Stock | |
| AMN Healthcare Services Inc | Denise L. Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 110.76 per share. | 06 Jan 2023 | 4,001 | 14,078 (0%) | 0% | 110.8 | 443,151 | Common Stock |
| Acadia Pharma Inc | Stephen R. Davis | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 06 Jan 2023 | 3,904 | 84,633 (0%) | 0% | 17.1 | 66,877 | Common Stock |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Hollings C. Renton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | James N. Topper | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| Helios Tech Inc | Jason Morgan | President, CVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,853 | 3,853 | - | - | Restricted Stock Units | |
| Helios Tech Inc | Jason Morgan | President, CVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,853 | 3,853 | - | - | Performance-Based Restricted Stock Units | |
| Northwestern Corp | Dana J. Dykhouse | Director | 06 Jan 2023 | 3,750 | 41,500 (0%) | 0% | 59.3 | 222,525 | Common Stock | |
| Outset Medical Inc | Steven Williamson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,641 | 130,188 | - | 0 | Common Stock | |
| First Internet Bancorp | Kenneth J. Lovik | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,598 | 38,639 (0%) | 0% | 0 | Common Stock | |
| Helios Tech Inc | Jason Morgan | President, CVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,500 | 3,500 | - | - | Restricted Stock Units | |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.59 per share. | 06 Jan 2023 | 3,308 | 501,026 (0%) | 0% | 121.6 | 402,228 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.59 per share. | 06 Jan 2023 | 3,307 | 487,091 (0%) | 0% | 121.6 | 402,106 | Class A Common Stock |
| TriNet Grp Inc | Alexander G. Warren | SVP, CHIEF REVENUE OFFICER | Sale of securities on an exchange or to another person at price $ 70.11 per share. | 06 Jan 2023 | 3,280 | 37,862 (0%) | 0% | 70.1 | 229,952 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 3,195 | 14,108 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.30 per share. | 06 Jan 2023 | 3,195 | 19,937 (0%) | 0% | 31.3 | 100,004 | Common Stock |
| Outset Medical Inc | Martin Vazquez | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,185 | 109,109 | - | 0 | Common Stock | |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | 06 Jan 2023 | 3,185 | 101,847 | - | 0 | Common Stock | ||
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 3,171 | 6,342 | - | - | Restricted Stock Units | |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 3,171 | 12,310 (0%) | 0% | - | Citizens, Inc. Class A Common Stock | |
| Parke Bancorp Inc | Daniel J. Dalton | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 06 Jan 2023 | 3,120 | 57,879 (0%) | 0% | 20.3 | 63,430 | Common Stock |
| Essent Grp Ltd | David B. Weinstock | VP, CAO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,118 | 10,742 | - | - | Restricted share units | |
| Helios Tech Inc | Matteo Arduini | President, QRC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,083 | 3,083 | - | - | Performance-Based Restricted Stock Units | |
| Helios Tech Inc | Matteo Arduini | President, QRC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,082 | 3,082 | - | - | Restricted Stock Units | |
| Regeneron Pharma | Michael S. Brown | Director | Sale of securities on an exchange or to another person at price $ 747.14 per share. | 06 Jan 2023 | 3,070 | 1,247 (0%) | 0% | 747.1 | 2,293,720 | Common Stock |
| Regeneron Pharma | Michael S. Brown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 3,070 | 6,142 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Michael S. Brown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 520.01 per share. | 06 Jan 2023 | 3,070 | 4,317 (0%) | 0% | 520.0 | 1,596,431 | Common Stock |
| Essent Grp Ltd | David B. Weinstock | VP, CAO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,010 | 7,624 | - | - | Restricted share units | |
| Helios Tech Inc | Matteo Arduini | President, QRC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Helios Tech Inc | Marc Greenberg | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Toro Co. | Richard W. Rodier | Group VP, Construction | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.38 per share. | 06 Jan 2023 | 3,000 | 26,736 (0%) | 0% | 31.4 | 94,125 | Common Stock |
| Toro Co. | Richard W. Rodier | Group VP, Construction | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 3,000 | 1,400 | - | - | Non-Qualified Stock Option | |
| Toro Co. | Richard W. Rodier | Group VP, Construction | Sale of securities on an exchange or to another person at price $ 112.72 per share. | 06 Jan 2023 | 3,000 | 23,736 (0%) | 0% | 112.7 | 338,151 | Common Stock |
| Helios Tech Inc | Marc Greenberg | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 2,906 | 2,906 | - | - | Restricted Stock Units | |
| Helios Tech Inc | Marc Greenberg | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 2,906 | 2,906 | - | - | Performance-Based Restricted Stock Units | |
| Caredx Inc | Michael D. Goldberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 2,896 | 72,572 (0%) | 0% | 0 | Common Stock | |
| Keysight Tech | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 2,844 | 0 (0%) | 0% | 0 | Common Stock | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 26.95 per share. | 06 Jan 2023 | 2,792 | 0 | - | 27.0 | 75,254 | Common Stock |
| Northwestern Corp | Linda G. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 59.34 per share. | 06 Jan 2023 | 2,750 | 21,660 (0%) | 0% | 59.3 | 163,185 | Common Stock |
| Northwestern Corp | Jan Robert Horsfall | Director | Grant, award, or other acquisition of securities at price $ 59.34 per share. | 06 Jan 2023 | 2,750 | 7,175 (0%) | 0% | 59.3 | 163,185 | Common Stock |
| Northwestern Corp | Kent T. Larson | Director | Grant, award, or other acquisition of securities at price $ 59.34 per share. | 06 Jan 2023 | 2,750 | 4,896 (0%) | 0% | 59.3 | 163,185 | Common Stock |
| Northwestern Corp | Britt E. Ide | Director | Grant, award, or other acquisition of securities at price $ 59.34 per share. | 06 Jan 2023 | 2,750 | 12,801 (0%) | 0% | 59.3 | 163,185 | Common Stock |
| Northwestern Corp | Anthony T. Clark | Director | Grant, award, or other acquisition of securities at price $ 59.34 per share. | 06 Jan 2023 | 2,750 | 20,099 (0%) | 0% | 59.3 | 163,185 | Common Stock |
| Teads Holding Co. | David Kostman | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.03 per share. | 06 Jan 2023 | 2,539 | 416,284 | - | 4.0 | 10,232 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Jan 2023 | 2,413 | 2,413 | - | 1.7 | 4,199 | Common Stock |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.83 per share. | 06 Jan 2023 | 2,305 | 299,746 | - | 4.8 | 11,133 | Class A Common Stock |
| Outset Medical Inc | John L. Brottem | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 2,184 | 72,062 | - | 0 | Common Stock | |
| Outset Medical Inc | Jean-Olivier Racine | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 2,184 | 81,354 | - | 0 | Common Stock | |
| Outset Medical Inc | Stacey L. Porter | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 1,939 | 66,830 | - | 0 | Common Stock | |
| Amylyx Pharma Inc | Joshua Cohen | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 06 Jan 2023 | 1,846 | 2,892,617 | - | 36.8 | 67,912 | Common Stock |
| Amylyx Pharma Inc | Justin Klee | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 06 Jan 2023 | 1,846 | 2,892,617 | - | 36.8 | 67,912 | Common Stock |
| Amylyx Pharma Inc | James M. Frates | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 06 Jan 2023 | 1,836 | 34,831 | - | 36.1 | 66,241 | Common Stock |
| Halliburton | Eric J. Carre | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.42 per share. | 06 Jan 2023 | 1,807 | 128,177 (0%) | 0% | 39.4 | 71,232 | Common Stock |
| Albemarle | Scott Tozier | EVP & CFO | Sale of securities on an exchange or to another person at price $ 220.00 per share. | 06 Jan 2023 | 1,719 | 63,384 (0%) | 0% | 220 | 378,180 | Common Stock |
| Teads Holding Co. | Yaron Galai | Director, Co-Founder and Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.03 per share. | 06 Jan 2023 | 1,693 | 3,622,834 | - | 4.0 | 6,823 | Common Stock |
| Prudential Financial | Douglas A. Scovanner | Director | 06 Jan 2023 | 1,693 | 16,091 (0%) | 0% | 0 | Common Stock | ||
| Prudential Financial | Douglas A. Scovanner | Director | 06 Jan 2023 | 1,693 | 14,256 | - | - | Notional Shares - Optional | ||
| Amylyx Pharma Inc | Margaret Olinger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 06 Jan 2023 | 1,660 | 215,098 | - | 36.1 | 59,891 | Common Stock |
| Acadia Pharma Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,633 | 19,286 (0%) | 0% | - | Common Stock | |
| Acadia Pharma Inc | Austin D. Kim | EVP,General Counsel, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,633 | 1,634 | - | - | Restricted Stock Units | |
| Halliburton | Jill D. Sharp | SVP Internal Assurance Svcs. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.43 per share. | 06 Jan 2023 | 1,555 | 55,444 (0%) | 0% | 38.4 | 59,759 | Common Stock |
| Kyntra Bio Inc | Enrique A. Conterno | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.95 per share. | 06 Jan 2023 | 1,538 | 295,483 (0%) | 0% | 19.9 | 30,683 | Common Stock |
| ServiceNow | Gina Mastantuono | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,529 | 6,116 | - | - | Restricted Stock Units | |
| ServiceNow | Gina Mastantuono | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,529 | 7,720 (0%) | 0% | 0 | Common Stock | |
| Brookfield Real Assets Income Fund Inc | Heather S. Goldman | Director | Purchase of securities on an exchange or from another person at price $ 16.79 per share. | 06 Jan 2023 | 1,525 | 1,539 (0%) | 0% | 16.8 | 25,605 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,507 | 28,629 | - | - | Stock Option (Right to Buy) | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.18 per share. | 06 Jan 2023 | 1,500 | 2,731,386 | - | 15.2 | 22,770 | Common Stock |
| Priority Technology Holdings | John Vito Priore | Director, Ten Percent Owner | 06 Jan 2023 | 1,476 | 9,324,316 (13%) | 0% | 5.3 | 7,764 | Common Stock | |
| T. Rowe Price Group | Robert W. Sharps | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,456 | 0 | - | - | Stock Option | |
| T. Rowe Price Group | Robert W. Sharps | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.61 per share. | 06 Jan 2023 | 1,456 | 469,693 (0%) | 0% | 68.6 | 99,892 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.69 per share. | 06 Jan 2023 | 1,415 | 482,384 (0%) | 0% | 120.7 | 170,782 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.69 per share. | 06 Jan 2023 | 1,414 | 499,612 (0%) | 0% | 120.7 | 170,661 | Class A Common Stock |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 06 Jan 2023 | 1,405 | 204,928 | - | 36.1 | 50,691 | Common Stock |
| Helios Tech Inc | Lee Wichlacz | President, Electronics | 06 Jan 2023 | 1,401 | 1,401 | - | - | Performance-Based Restricted Stock Units | ||
| Helios Tech Inc | Lee Wichlacz | President, Electronics | 06 Jan 2023 | 1,400 | 1,400 | - | - | Restricted Stock Units | ||
| Veeco Instruments Inc | Susan Wilkerson | SVP, GLOBAL SALES & SERVICE | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 06 Jan 2023 | 1,382 | 64,703 (0%) | 0% | 15.4 | 21,250 | Common Stock |
| Allegro Microsystems Inc | Joanne Valente | SVP, CHRO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 06 Jan 2023 | 1,377 | 95,776 | - | 30.0 | 41,315 | Common Stock |
| Genasys Inc | Dennis D. Klahn | CFO/Secretary | 06 Jan 2023 | 1,369 | 30,434 (0%) | 0% | 3.7 | 5,093 | Common Stock | |
| Genasys Inc | Dennis D. Klahn | CFO/Secretary | 06 Jan 2023 | 1,369 | 27,696 (0%) | 0% | 3.5 | 4,833 | Common Stock | |
| Genasys Inc | Dennis D. Klahn | CFO/Secretary | 06 Jan 2023 | 1,369 | 29,065 (0%) | 0% | 3.8 | 5,257 | Common Stock | |
| Black Stone Minerals L.P. - Unit | Alexander D. Stuart | Director | Grant, award, or other acquisition of securities at price $ 16.87 per share. | 06 Jan 2023 | 1,333 | 139,356 (0%) | 0% | 16.9 | 22,488 | Common units representing limited partner interests |
| Caredx Inc | George W. Bickerstaff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 1,323 | 61,424 (0%) | 0% | 0 | Common Stock | |
| Priority Technology Holdings | Christina M. Favilla | Director | Sale or transfer of securities back to the company at price $ 5.26 per share. | 06 Jan 2023 | 1,319 | 82,047 (0%) | 0% | 5.3 | 6,938 | Common Stock |
| Buckle Inc | Karen B. Rhoads | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 1,300 | 224,739 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 122.67 per share. | 06 Jan 2023 | 1,300 | 485,791 (0%) | 0% | 122.7 | 159,467 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 122.67 per share. | 06 Jan 2023 | 1,300 | 504,334 (0%) | 0% | 122.7 | 159,467 | Class A Common Stock |
| Acadia Pharma Inc | Brendan P. Teehan | EVP, COO, Head of Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,286 | 5,081 (0%) | 0% | - | Common Stock | |
| Acadia Pharma Inc | Brendan P. Teehan | EVP, COO, Head of Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,286 | 1,287 | - | - | Restricted Stock Units | |
| Acadia Pharma Inc | Brendan P. Teehan | EVP, COO, Head of Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,286 | 2,573 | - | - | Restricted Stock Units | |
| Priority Technology Holdings | Michael K. Passilla | Director | Sale or transfer of securities back to the company at price $ 5.26 per share. | 06 Jan 2023 | 1,280 | 82,086 (0%) | 0% | 5.3 | 6,733 | Common Stock |
| AMN Healthcare Services Inc | Denise L. Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,259 | 0 | - | - | Restricted Stock Units | |
| Black Stone Minerals L.P. - Unit | William N. Mathis | Director | 06 Jan 2023 | 1,259 | 191,840 (0%) | 0% | 16.9 | 21,239 | Common units representing limited partner interests | |
| DoorDash | Shona L. Brown | Director | Sale of securities on an exchange or to another person at price $ 47.32 per share. | 06 Jan 2023 | 1,250 | 82,278 | - | 47.3 | 59,150 | Class A Common Stock |
| Wendy`s Co (Class A) | Peter W. May | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 23.04 per share. | 06 Jan 2023 | 1,236 | 5,482,049 (2%) | 0% | 23.0 | 28,477 | Common Stock |
| Mechanics Bancorp. (Class A) | Douglas Irvine Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 1,227 | 126,562 (0%) | 0% | 0 | Common Stock | |
| SouthState Corp | Renee Brooks | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.45 per share. | 06 Jan 2023 | 1,223 | 30,328 (0%) | 0% | 41.4 | 50,693 | Common Stock |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,203 | 0 | - | - | Restricted Stock Units | |
| Leggett & Platt Inc | Robert E. Brunner | Director | Grant, award, or other acquisition of securities at price $ 27.06 per share. | 06 Jan 2023 | 1,201 | 52,479 (0%) | 0% | 27.1 | 32,500 | Common Stock |
| Leggett & Platt Inc | Joseph W. Mcclanathan | Director | Grant, award, or other acquisition of securities at price $ 27.07 per share. | 06 Jan 2023 | 1,136 | 40,759 (0%) | 0% | 27.1 | 30,750 | Common Stock |
| SEMrush Holdings Inc (Class A) | Delbert M. Humenik | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 06 Jan 2023 | 1,130 | 90,073 | - | 8.1 | 9,198 | Class A Common Stock |
| Wendy`s Co (Class A) | Matthew H. Peltz | Director | 06 Jan 2023 | 1,119 | 86,782 (0%) | 0% | 23.0 | 25,782 | Common Stock | |
| Black Stone Minerals L.P. - Unit | Jerry V. Kyle | Director | Grant, award, or other acquisition of securities at price $ 16.87 per share. | 06 Jan 2023 | 1,111 | 252,460 (0%) | 0% | 16.9 | 18,743 | Common units representing limited partner interests |
| Black Stone Minerals L.P. - Unit | William E. Randall | Director | Grant, award, or other acquisition of securities at price $ 16.87 per share. | 06 Jan 2023 | 1,111 | 122,712 (0%) | 0% | 16.9 | 18,743 | Common units representing limited partner interests |
| Wendy`s Co (Class A) | Michelle J. Mathews-Spradlin | Director | Grant, award, or other acquisition of securities at price $ 23.04 per share. | 06 Jan 2023 | 1,101 | 68,948 (0%) | 0% | 23.0 | 25,367 | Common Stock |
| Avnet Inc | Rebeca Obregon-Jimenez | SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.53 per share. | 06 Jan 2023 | 1,096 | 12,128 (0%) | 0% | 41.5 | 45,517 | Common Stock |
| Leggett & Platt Inc | Jai Shah | Director | Grant, award, or other acquisition of securities at price $ 27.06 per share. | 06 Jan 2023 | 1,090 | 18,931 (0%) | 0% | 27.1 | 29,500 | Common Stock |
| Dycom Ind Inc | Daniel S. Peyovich | Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.43 per share. | 06 Jan 2023 | 1,087 | 22,680 (0%) | 0% | 93.4 | 101,558 | Common Stock |
| Leggett & Platt Inc | Manuel A. Fernandez | Director | 06 Jan 2023 | 1,062 | 49,368 (0%) | 0% | 27.1 | 28,750 | Common Stock | |
| Caredx Inc | Fred E. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 1,062 | 113,748 (0%) | 0% | 0 | Common Stock | |
| General Mills | Mark Pallot | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 85.99 per share. | 06 Jan 2023 | 1,033 | 17,145 (0%) | 0% | 86.0 | 88,828 | Common Stock |
| General Mills | Mark Pallot | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.52 per share. | 06 Jan 2023 | 1,033 | 18,178 (0%) | 0% | 66.5 | 68,715 | Common Stock |
| General Mills | Mark Pallot | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,033 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,018 | 27,497 | - | - | Stock Option (Right to Buy) | |
| AMN Healthcare Services Inc | Denise L. Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 109.30 per share. | 06 Jan 2023 | 1,002 | 18,079 (0%) | 0% | 109.3 | 109,519 | Common Stock |
| Cooper Companies | Jody S. Lindell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,000 | 2,227 | - | - | Stock Options (Right to Buy) | |
| Cooper Companies | Jody S. Lindell | Director | Sale of securities on an exchange or to another person at price $ 344.30 per share. | 06 Jan 2023 | 1,000 | 13,543 (0%) | 0% | 344.3 | 344,304 | Common Stock |
| Cooper Companies | Jody S. Lindell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.35 per share. | 06 Jan 2023 | 1,000 | 14,543 (0%) | 0% | 128.4 | 128,350 | Common Stock |
| Mechanics Bancorp. (Class A) | Joanne R. Harrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 976 | 3,345 (0%) | 0% | 0 | Common Stock | |
| FiscalNote Holdings Inc (Class A) | Gerald Yao | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.14 per share. | 06 Jan 2023 | 971 | 86,971 | - | 6.1 | 5,962 | Class A Common Stock |
| Mechanics Bancorp. (Class A) | Nancy D. Pellegrino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 948 | 8,100 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 06 Jan 2023 | 939 | 484,852 (0%) | 0% | 123.6 | 116,089 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 06 Jan 2023 | 938 | 506,234 (0%) | 0% | 123.6 | 115,965 | Class A Common Stock |
| Enovix Corp | Steffen Pietzke | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 06 Jan 2023 | 922 | 536,216 | - | 8.0 | 7,422 | Common Stock |
| General Mills | Mark Pallot | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 85.99 per share. | 06 Jan 2023 | 922 | 17,145 (0%) | 0% | 86.0 | 79,283 | Common Stock |
| General Mills | Mark Pallot | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.72 per share. | 06 Jan 2023 | 922 | 18,067 (0%) | 0% | 55.7 | 51,374 | Common Stock |
| General Mills | Mark Pallot | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 922 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 906 | 10,866 | - | - | Stock Option (Right to Buy) | |
| T. Rowe Price Group | Robert W. Sharps | CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.29 per share. | 06 Jan 2023 | 890 | 468,803 (0%) | 0% | 112.3 | 99,938 | Common Stock |
| AMN Healthcare Services Inc | Denise L. Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 889 | 19,451 (0%) | 0% | 0 | Common Stock | |
| Wendy`s Co (Class A) | Nelson Peltz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 23.04 per share. | 06 Jan 2023 | 873 | 9,956,248 (4%) | 0% | 23.0 | 20,114 | Common Stock |
| Caredx Inc | Peter Maag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 834 | 298,507 (0%) | 0% | 0 | Common Stock | |
| Amylyx Pharma Inc | James M. Frates | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 06 Jan 2023 | 822 | 34,009 | - | 36.8 | 30,240 | Common Stock |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 787 | 21,688 (0%) | 0% | 0 | Common Stock | |
| Citizens Inc (Class A) | Sheryl Kinlaw | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 06 Jan 2023 | 773 | 11,537 (0%) | 0% | 3.7 | 2,868 | Citizens, Inc. Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 119.60 per share. | 06 Jan 2023 | 754 | 507,472 (0%) | 0% | 119.6 | 90,180 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 119.60 per share. | 06 Jan 2023 | 753 | 483,799 (0%) | 0% | 119.6 | 90,060 | Class A Common Stock |
| Amylyx Pharma Inc | Margaret Olinger | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 06 Jan 2023 | 743 | 214,355 | - | 36.8 | 27,334 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 725 | 148,157 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Salesforce | Marc Benioff | Director, Chair and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.57 per share. | 06 Jan 2023 | 725 | 27,754,334 (3%) | 0% | 75.6 | 54,788 | Common Stock |
| Aramark | Greg Creed | Director | Grant, award, or other acquisition of securities at price $ 43.95 per share. | 06 Jan 2023 | 711 | 22,354 (0%) | 0% | 43.9 | 31,248 | Common Stock |
| SouthState Corp | Renee Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.55 per share. | 06 Jan 2023 | 687 | 29,641 (0%) | 0% | 77.6 | 53,277 | Common Stock |
| Caredx Inc | Hannah A. Valantine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 676 | 8,047 (0%) | 0% | 0 | Common Stock | |
| Mechanics Bancorp. (Class A) | Mark R. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 651 | 17,476 (0%) | 0% | 0 | Common Stock | |
| LendingTree Inc | M. Lisa Young | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 646 | 646 | - | - | Restricted Stock Units | |
| LendingTree Inc | M. Lisa Young | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 646 | 1,410 (0%) | 0% | 0 | Common Stock | |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 06 Jan 2023 | 629 | 204,299 | - | 36.8 | 23,140 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 117.16 per share. | 06 Jan 2023 | 600 | 490,398 (0%) | 0% | 117.2 | 70,296 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 117.16 per share. | 06 Jan 2023 | 600 | 505,634 (0%) | 0% | 117.2 | 70,296 | Class A Common Stock |
| Acadia Pharma Inc | Austin D. Kim | EVP,General Counsel, Secretary | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 06 Jan 2023 | 589 | 18,697 (0%) | 0% | 17.1 | 10,090 | Common Stock |
| MainStreet Bancshares Inc | Darrell Green | Director | Grant, award, or other acquisition of securities at price $ 26.88 per share. | 06 Jan 2023 | 558 | 25,038 (0%) | 0% | 26.9 | 14,999 | Common Stock |
| MainStreet Bancshares Inc | Rafael E. DeLeon | Director | Grant, award, or other acquisition of securities at price $ 26.88 per share. | 06 Jan 2023 | 558 | 3,823 (0%) | 0% | 26.9 | 14,999 | Common Stock |
| ServiceNow | Gina Mastantuono | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.53 per share. | 06 Jan 2023 | 555 | 7,165 (0%) | 0% | 366.5 | 203,424 | Common Stock |
| Mechanics Bancorp. (Class A) | Sandra A. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 534 | 12,887 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharma Inc | Brendan P. Teehan | EVP, COO, Head of Commercial | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 06 Jan 2023 | 532 | 4,549 (0%) | 0% | 17.1 | 9,113 | Common Stock |
| Leggett & Platt Inc | Judy C. Odom | Director | Grant, award, or other acquisition of securities at price $ 27.07 per share. | 06 Jan 2023 | 531 | 68,488 (0%) | 0% | 27.1 | 14,375 | Common Stock |
| Wendy`s Co (Class A) | Kristin A. Dolan | Director | Grant, award, or other acquisition of securities at price $ 23.04 per share. | 06 Jan 2023 | 526 | 41,340 (0%) | 0% | 23.0 | 12,119 | Common Stock |
| Worthington Ind Inc | Joseph B. Hayek | VP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 500 | 130,335 (0%) | 0% | 0 | Common Shares | |
| Illumina Inc | Susan H. Tousi | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 204.58 per share. | 06 Jan 2023 | 500 | 38,662 (0%) | 0% | 204.6 | 102,290 | Common Stock |
| Bank7 Corp | Thomas L. Travis | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.56 per share. | 06 Jan 2023 | 476 | 326,775 (3%) | 0% | 26.6 | 12,643 | Common stock, par value $0.01 per share |
| Mechanics Bancorp. (Class A) | Scott M. Boggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 465 | 29,133 (0%) | 0% | 0 | Common Stock | |
| Mechanics Bancorp. (Class A) | James R. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 465 | 8,845 (0%) | 0% | 0 | Common Stock | |
| Teads Holding Co. | Jason Kiviat | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.03 per share. | 06 Jan 2023 | 461 | 130,389 | - | 4.0 | 1,858 | Common Stock |
| Teads Holding Co. | Wenkai Bradshaw | CAO & VP Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.03 per share. | 06 Jan 2023 | 461 | 98,844 | - | 4.0 | 1,858 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 444 | 890 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 06 Jan 2023 | 444 | 95,128 | - | 5.0 | 2,211 | Common Stock |
| Citizens & Northern Corp | Frank G. Pellegrino | Director | Purchase of securities on an exchange or from another person at price $ 23.17 per share. | 06 Jan 2023 | 438 | 29,435 (0%) | 0% | 23.2 | 10,149 | Common Stock |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.16 per share. | 06 Jan 2023 | 416 | 21,272 (0%) | 0% | 107.2 | 44,579 | Common Stock |
| Tarsus Pharma Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 06 Jan 2023 | 411 | 1,129,740 | - | 15 | 6,165 | Common Stock |
| Worthington Ind Inc | Joseph B. Hayek | VP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 400 | 130,835 (0%) | 0% | 0 | Common Shares | |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 06 Jan 2023 | 400 | 15,643 (0%) | 0% | 125 | 50,000 | Common Stock |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 400 | 53,143 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.24 per share. | 06 Jan 2023 | 400 | 16,043 (0%) | 0% | 43.2 | 17,296 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 06 Jan 2023 | 388 | 36,582 (0%) | 0% | 5.2 | 2,006 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 06 Jan 2023 | 388 | 36,194 (0%) | 0% | 6.4 | 2,487 | Common Stock |
| Bank7 Corp | Jason E. Estes | Executive Vice President; CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.56 per share. | 06 Jan 2023 | 379 | 60,495 (0%) | 0% | 26.6 | 10,066 | Common stock, par value $0.01 per share |
| AMN Healthcare Services Inc | Denise L. Jackson | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.16 per share. | 06 Jan 2023 | 370 | 19,081 (0%) | 0% | 107.2 | 39,649 | Common Stock |
| Gibraltar Ind Inc | Linda K. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 369 | 1,480 | - | - | Restricted Stock Unit (MSPP Post-2012) | |
| Gibraltar Ind Inc | Manish H. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 369 | 2,192 | - | - | Restricted Stock Unit (MSPP Post-2012) | |
| Lakeland Fin Corp | Bradley J. Toothaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 344 | 14,782 | - | - | Phantom Stock | |
| Lakeland Fin Corp | Darrianne P. Christian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 310 | 2,767 | - | - | Phantom Stock | |
| Lakeland Fin Corp | Blake W. Augsburger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 309 | 14,826 | - | - | Phantom Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.38 per share. | 06 Jan 2023 | 300 | 484,552 (0%) | 0% | 118.4 | 35,514 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.38 per share. | 06 Jan 2023 | 300 | 507,172 (0%) | 0% | 118.4 | 35,514 | Class A Common Stock |
| MainStreet Bancshares Inc | Patsy I. Rust | Director | Grant, award, or other acquisition of securities at price $ 26.88 per share. | 06 Jan 2023 | 279 | 21,981 (0%) | 0% | 26.9 | 7,500 | Common Stock |
| Bank7 Corp | John T. Phillips | Director, Sr. EVP; COO; and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.56 per share. | 06 Jan 2023 | 275 | 13,230 (0%) | 0% | 26.6 | 7,304 | Common stock, par value $0.01 per share |
| Citizens & Northern Corp | Bobbi J. Kilmer | Director | Purchase of securities on an exchange or from another person at price $ 23.17 per share. | 06 Jan 2023 | 269 | 11,343 (0%) | 0% | 23.2 | 6,233 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 06 Jan 2023 | 268 | 94,684 | - | 2.1 | 565 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 268 | 1,067 | - | - | Stock Option (Right to Buy) | |
| Parke Bancorp Inc | Daniel J. Dalton | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 20.47 per share. | 06 Jan 2023 | 250 | 57,629 (0%) | 0% | 20.5 | 5,118 | Common Stock |
| Lakeland Fin Corp | Brian J. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 241 | 17,194 | - | - | Phantom Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.